System for demand-based adminstration of insulin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4403984
SERIAL NO

06218710

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A system is disclosed for demand-based administration of insulin which utilizes a change in a physical property of a patient's body fluid as an indicator that a change in the body fluid glucose level has occurred and that an appropriate amount of insulin should be supplied to the patient. Body fluid osmolality or one of its colligative properties are particularly suitable for this purpose. A second sensor for measuring such properties as electrical conductivity may be added to detect changes in osmolality caused by such factors as dehydration. Insulin can be delivered to the patient from an extracorporeal source by means of a dual lumen catheter. One lumen of the catheter provides a passageway for the insulin dose and the other lumen provides a passageway through which a replaceable sensors can be introduced into or removed from the patient's body. In the alternative, the entire insulin administration system can be implanted into the patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOTEK INC A CORP OF NEVNot Provided

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ash, Stephen R Lafayette, IN 71 9263
Loeb, Marvin P Chicago, IL 62 6530

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation